Skip to main content

Table 1 Overview of 19F MRI applications in cell therapy for cancer. SC = subcutaneously, LN = lymph node, CNS = central nervous system, * = clinical trial

From: Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer

Cell type

Recipient species

model

Tracer agent

Therapy delivery route

Imaging post-transfer (day)

Key findings

Reference

T-cell therapy

 Primary BALB/c mouse T-cells

BALB/c mouse

N/A

BODIPy-TR PFPE

Intraperitoneal

2

T cell homing to the abdominal LN

[22]

 Human CAR T against EGFRvIII

SCID mouse

glioblastoma SC

CS-1000 ATM

Intravenously

2, 7, 14

CAR T cell homing to the tumors and spleen, reduced tumor growth

[40]

 DO11.10 mouse T cells

BALB/c mouse

chicken ova SC

PFPE/PFPE –Alexa657

Intraperitoneal

4, 7, 11, 21

T cell homing to the draining inguinal LN and persistence over 3 weeks

[35]

 Naïve T cells, OT-1 T cells

C57BL/6 mouse

melanoma expressing ova

CS-1000 ATM

Intravenously

1

No signal found in the tumor, but found in the chest (lungs), abdomen (liver), and left flank (spleen)

[41]

 Pmel-1 cytotoxic T cells

C57BL/6 mouse

CNS glioma

PCE

Intravenously

3, 5, 7, 12

Significant pO2 increase in Pmel-1 treated mice at day 5 compared to controls

[71]

NK cell therapy

 Human NK cells

NSG mouse

neuroblastoma SC

CS-1000 ATM

Subcutaneously or intratumorally

1, 3, 7/8, 10, 15

NK cell detection and persistence at injection sites, no evidence of migration

[37]

 Human NK cells

NSG mouse

meduloblastoma CNS

CS-ATM DM Green

Intratumorally

0

In vivo visualization of NK cells after transfer

[36]

DC vaccines

 Mouse bone marrow-derived DC

C57BL/6 mouse

N/A

PCE

Intradermally in the limb

1

Migration of antigen-loaded DC from the footpad to the draining lymph node

[32]

 In situ DC labeling

C57BL/6 mouse

CNS glioma

Rhodamine-PCE

Intravenously

1

Migration if In situ labeled DC to CNS tumors, reduced tumor growth

[59]

 Mouse bone marrow-derived DC

C57BL/6 mouse

N/A

Rhodamine-PCE

Intradermally in the limb

0

Migration of Erk−/− DC to the draining popliteal lymph node

[59]

 Autologous human DC vaccine*

Human

Metastatic colorectal cancer

CS-1000 (PFPE)

Intradermally in quadriceps

0, 1

Succesful first-in-man detection of DC vaccine in patients

[14]

PBMCs

 Human PBMC

Nude mouse, ham shank

N/A

CS-1000 ATM

Intradermally and Intramuscularly

0, 2

Clinical protocol implementation for detection of PBMC in skin and muscle at 1.2 cm depth

[61]